Topamax Lawsuit

March 4, 2011 – The Food and Drug Administration (FDA) issued a safety announcement on Topamax, a topiramate drug used, either alone or in combination with other drugs, in the treatment of epileptic seizures and to prevent migraine headaches.

The announcement is based on information collected from human data that lead the FDA to reclassify topiramates, such as Topamax, from a Pregnancy Category C drug, to a Pregnancy Category D drug.

Pregnancy Category C drugs are those that testing indicated may cause birth defects, while a Pregnancy Category D drug is one that has shown positive evidence for risks to the fetus based on data gathered from human usage.

If you took Topamax while pregnant, you could have just cause to file a Topamax lawsuit for compensation to assist in paying the costly medical bills needed to treat your child's birth defect. Personal injury lawyers O’Hanlon, McCollom & Demerath would like to invite you to contact them for a consultation.

O’Hanlon, McCollom & Demerath
Personal Injury Lawyers
808 West Avenue
Austin, TX. 78701

phone: 512-494-9949

Note that in their safety announcement the FDA stated that there are cases where the risks of taking Topamax, and other topiramates, by pregnant women may be acceptable due to the specific benefits of the drug in the treatment of epileptic seizures.